![Kelley Dealhoy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelley Dealhoy
Corporate Officer/Principal chez
DECIPHERA PHARMACEUTICALS, INC.
Profil
Kelley Dealhoy is currently the Chief Business Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Prior to this, she worked as the Vice President-Business Development at Novartis AG.
She completed her undergraduate degree at Queen's University.
Postes actifs de Kelley Dealhoy
| Sociétés | Poste | Début |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 16/06/2022 |
Anciens postes connus de Kelley Dealhoy
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | - |
Formation de Kelley Dealhoy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
